Literature DB >> 27314842

Retrograde dynamic locked intramedullary nailing for aseptic supracondylar femoral nonunion after dynamic condylar screw treatment.

Chi-Chuan Wu1.   

Abstract

OBJECTIVE: Supracondylar femoral nonunions after dynamic condylar screw (DCS) treatment are uncommon, and few studies have addressed an optimal treatment technique for this disorder. Re-insertion of a new plate may not be secure because of bony defects in the distal fragment, created by the lag screw of the DCS.
MATERIALS AND METHODS: Forty-two consecutive adult patients with 42 supracondylar femoral nonunions were treated with removal of the DCS, re-alignment of the knee axis, and insertion of a retrograde dynamic traditional femoral locked nail. When necessary, a humeral plate was augmented to reinforce rotational stability.
RESULTS: A final group of 36 patients with 36 nonunions were followed for an average of 2.8 years (range 1.1-6.2 years). All nonunions healed with a union rate of 100 %, and the average time to union was 4.2 months (range 2.5-5.5 months). Complications included two malunions. There were no instances of nonunion or deep infection. Satisfactory knee function among 36 patients improved from 8.2 % preoperatively to 86.1 % at the last follow-up (p < 0.001). All 36 patients could walk without aids.
CONCLUSION: The described technique may be an excellent alternative treatment for an aseptic supracondylar femoral nonunion after DCS treatment. The technique is not difficult, and the union rate and satisfactory rate are high.

Entities:  

Keywords:  Aseptic nonunion; Dynamic condylar screw; Retrograde locked nail; Supracondylar femoral fracture

Mesh:

Year:  2016        PMID: 27314842     DOI: 10.1007/s00590-016-1800-0

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  37 in total

1.  Supracondylar femoral fractures in elderly patients treated with the dynamic condylar screw and the retrograde intramedullary nail: a comparative study of the two methods.

Authors:  A Christodoulou; I Terzidis; A Ploumis; S Metsovitis; A Koukoulidis; C Toptsis
Journal:  Arch Orthop Trauma Surg       Date:  2004-12-21       Impact factor: 3.067

Review 2.  Distal femoral fractures: current treatment, results and problems.

Authors:  M Stover
Journal:  Injury       Date:  2001-12       Impact factor: 2.586

3.  Distal femoral nonunion: treatment with a retrograde inserted locked intramedullary nail.

Authors:  K J Koval; D Seligson; H Rosen; K Fee
Journal:  J Orthop Trauma       Date:  1995       Impact factor: 2.512

4.  Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses.

Authors:  R B Gustilo; J T Anderson
Journal:  J Bone Joint Surg Am       Date:  1976-06       Impact factor: 5.284

5.  The treatment of nonunions following intramedullary nailing of femoral shaft fractures.

Authors:  Harri K Pihlajamäki; Sari T Salminen; Ole M Böstman
Journal:  J Orthop Trauma       Date:  2002-07       Impact factor: 2.512

6.  Complications of surgically treated supracondylar fractures of the femur.

Authors:  T J Moore; T Watson; S A Green; D E Garland; R W Chandler
Journal:  J Trauma       Date:  1987-04

7.  Surgical treatment of displaced, comminuted fractures of the distal end of the femur.

Authors:  R D Mize; R W Bucholz; D P Grogan
Journal:  J Bone Joint Surg Am       Date:  1982-07       Impact factor: 5.284

8.  Retrograde dynamic locked nailing for femoral supracondylar nonunions after plating.

Authors:  Chi-Chuan Wu
Journal:  J Trauma       Date:  2009-01

9.  Closed locked intramedullary nailing. Its application to comminuted fractures of the femur.

Authors:  I Kempf; A Grosse; G Beck
Journal:  J Bone Joint Surg Am       Date:  1985-06       Impact factor: 5.284

10.  Immediate weight bearing of comminuted supracondylar femur fractures using locked plate fixation.

Authors:  Jaymes D Granata; Alan S Litsky; David P Lustenberger; Robert A Probe; Thomas J Ellis
Journal:  Orthopedics       Date:  2012-08-01       Impact factor: 1.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.